Results 81 to 90 of about 4,911,045 (202)

Amitriptyline induced Acute Dyskinesia

open access: yes, 2019
Overall prevalence of tricyclic antidepressants (TCA’s) causing extra-pyramidal features are low. Amongst them acute dyskinesia is not a commonly seen clinical presentation. Here, I describe a case of acute dyskinesia induced by amitriptyline.
Mithun S., S, Mithun S
core   +1 more source

Primary ciliary dyskinesia (Pcd) in Austria

open access: yes, 2009
Primary ciliary dyskinesia (PCD) is a rare hereditary recessive disease with symptoms of recurrent pneumonia, chronic bronchitis, bronchiectasis, and chronic sinusitis.
STRIPPOLI MP   +6 more
core  

Resting tremor in Parkinson disease: a negative predictor of levodopa-induced dyskinesia

open access: yes, 2011
It is unclear whether patients with different clinical subtypes of Parkinson disease (PD) differ in their risk of developing levodopa-induced dyskinesia (LID) and whether resting tremor is negatively correlated with this ...
Kipfer, Stefan   +4 more
core   +1 more source

Stratification of the risk of developing tardive drug-induced complications

open access: yesОбозрение психиатрии и медицинской психологии имени В.М. Бехтерева, 2018
Tardive drug dystonia / dyskinesia is one of the rare, and at the same time, the most severe motor complications associated with the use of pharmacological drugs. Complex assessment of risk factors for the development of tardive drug-induced side effects
L. A. Khublarova   +2 more
doaj  

Randomized clinical trial of topiramate for levodopa-induced dyskinesia in Parkinson's disease

open access: yes, 2014
BACKGROUND: The antiepileptic drug topiramate reduces levodopa-induced dyskinesia without exacerbating parkinsonism in animal models. We report a randomized, double-blind, placebo-controlled crossover trial in patients with Parkinson's disease and ...
Kobylecki, Christopher; id_orcid   +5 more
core   +1 more source

Tetrabenazine-induced oculogyric crisis – a rare complication in the treatment of Gilles de la Tourette syndrome

open access: yesNeuropsychiatric Disease and Treatment, 2016
Piotr Janik,1 Monika Figura1,2 1Department of Neurology, Anna Gostynska Wolski Hospital, 2Department of Neurology, Faculty of Health Sciences, Medical University of Warsaw, Warsaw, Poland Abstract: Tetrabenazine is used in the treatment of chorea ...
Janik P, Figura M
doaj  

Induced Seismicity Task Force Submits Seismic Action Plan To Governor Sam Brownback [2014]

open access: yes, 2014
October 1 ...
Kansas Induced Seismicity State Task Force.
core  

Randomized clinical trial of topiramate for levodopa-induced dyskinesia in Parkinson\u27s disease

open access: yes
Background: The antiepileptic drug topiramate reduces levodopa-induced dyskinesia without exacerbating parkinsonism in animal models. We report a randomized, double-blind, placebo-controlled crossover trial in patients with Parkinson\u27s disease and ...
Kass-Iliyya L   +5 more
core   +4 more sources

Methylphenidate-Induced Acute Orofacial and Extremity Dyskinesia

open access: yes, 2013
Methylphenidate is a short-acting stimulant. In this article, the authors report a 7-year-old male patient who presented with orofacial and limb dyskinesia after his first dose of methylphenidate treatment for a diagnosis of attention-deficit ...
Yilmaz, Ayse Esra   +5 more
core   +1 more source

AMPA receptor blockade improves levodopa-induced dyskinesia in MPTP monkeys

open access: yes, 2000
OBJECTIVE: To evaluate the contribution of amino-3-hydroxy-5-methyl-4-isoxazole proprionic acid (AMPA) glutamate receptors to the pathogenesis of parkinsonian signs and levodopa-induced dyskinesias. BACKGROUND: Motor fluctuations and dyskinesias reflect,
Blanchet, P. J.   +4 more
core  

Home - About - Disclaimer - Privacy